📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis. (2022)

First Author: Jackson C

Attributed to: Evidence Synthesis to inform health related decision making funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0275321

PubMed Identifier: 36454979

Publication URI: http://europepmc.org/abstract/MED/36454979

Type: Journal Article/Review

Volume: 17

Parent Publication: PloS one

Issue: 12

ISSN: 1932-6203